Vanessa Research, Inc. Logo
Our company

Innovative solutions, improved quality of life

At Vanessa Research, we are committed to improving our patients’ quality of life by innovating solutions for their treatment and care.

Back to the open positions

Our company

The cornerstone of our company is “research”: everyone, from senior scientist to
intern, is involved in the research of new ideas, technologies, and markets. Our core
area of research is diarrheal diseases such as cholera and the rare genetic microvillus inclusion disease.


Our free-thinking culture empowers us to dream of innovative products and solutions. Our company was founded on the desire to build a sustainable, innovative, entrepreneurial organization to create novel healthcare solutions in areas of unmet needs.


Our company has etched its niche in addressing complex ideas with simple solutions. Our flagship product, Shylicine™, is a cocktail designed to improve prognosis and quality of life for children with microvillus inclusion disease (MVID). Other products in our growing portfolio will provide ingenious solutions in the fields of women’s health, skin care, and laboratory research.


Often, certain healthcare markets can be overlooked for being “rare” or “less profitable.” At Vanessa Research, we are committed to improving upon access to care while decreasing the cost of healthcare delivery for patients whose needs have been previously overlooked. By addressing these markets, we give hope where none existed.

Stay connected

Subscribe to receive updates on our research, product development, and new initiatives.

You have the right to withdraw your consent by unsubscribing at any time.